Cerner (Nasdaq: CERN ) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Cerner's revenues will expand 13.9% and EPS will expand 10.0%.
The average estimate for revenue is $725.7 million. On the bottom line, the average EPS estimate is $0.33.
Last quarter, Cerner booked revenue of $680.0 million. GAAP reported sales were 5.7% higher than the prior-year quarter's $629.7 million.
Last quarter, non-GAAP EPS came in at $0.33. GAAP EPS of $0.31 for Q1 were 19% higher than the prior-year quarter's $0.26 per share.
For the preceding quarter, gross margin was 83.1%, 640 basis points better than the prior-year quarter. Operating margin was 23.5%, 330 basis points better than the prior-year quarter. Net margin was 16.5%, 240 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $2.99 billion. The average EPS estimate is $1.38.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 416 members out of 463 rating the stock outperform, and 47 members rating it underperform. Among 137 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 130 give Cerner a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cerner is outperform, with an average price target of $46.49.
Is Cerner the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Cerner to My Watchlist.